Humoral Response After Two Doses of COVISHIELD < sup > TM < /sup > Vaccine in Patients Undergoing Maintenance Hemodialysis
CONCLUSION: In MHD patients, two doses of the COVISHIELDTM vaccine induced a substantial humoral response. Prior history of COVID-19 resulted in a higher antibody response. Thus, the COVISHIELDTM vaccine is efficacious and safe for use in patients with MHD. How to cite this article: Balwani MR, Pasari AS, Baw.ule C, et al. Humoral Response After Two Doses of COVISHIELDTM Vaccine in Patients Undergoing Maintenance Hemodialysis. J Assoc Physicians India 2023;71(9):56-60.PMID:38700302 | DOI:10.59556/japi.71.0313
Source: Journal of the Association of Physicians of India - Category: General Medicine Authors: Manish R Balwani Amit S Pasari Charulata Bawankule Amol Bhawane Priyanka Tolani Vijay M Katekhaye Source Type: research
More News: Cardiology | Coronavirus | Covid Vaccine | COVID-19 | Diabetes | Diabetes Mellitus | Dialysis | Endocrinology | General Medicine | Heart | Heart Disease | Hemodialysis | Hypertension | India Health | Study | Vaccines